Imagen de Portada

Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Taro Igarashi, Shinsuke Mizoguchi, Kanako Matsuoka, Tadanobu Kamijo, Shota Kawano, Akira Furuta, Yasuyuki Suzuki, Takahiro Kimura, Laura E. Pascal, Zhou Wang, Naoki Yoshimura
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	The Prostate
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Influence of microbiome in intraprostatic inflammation and prostate cancer
por: Pranav Prakash, et al.
Publicado: (2024)

Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer patients
por: Tokiyoshi Tanegashima, et al.
Publicado: (2024)

Reply to Letter to the Editor on “Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer patients”
por: Tokiyoshi Tanegashima, et al.
Publicado: (2024)

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer
por: Catherine H. Marshall, et al.
Publicado: (2024)

A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin‐induced apoptosis in castration‐resistant prostate cancer
por: Pei‐Chen Ye, et al.
Publicado: (2024)

Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
por: Eric V. Li, et al.
Publicado: (2024)

Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study
por: Takafumi Yanagisawa, et al.
Publicado: (2024)

Does larger prostate size provide protection for cancer specific outcomes in localized prostate cancer
por: Zain Abedali, et al.
Publicado: (2024)

Cutibacterium acnes invades prostate epithelial cells to induce BRCAness as a possible pathogen of prostate cancer
por: Shingo Ashida, et al.
Publicado: (2024)

Diagnosis and management of neuroendocrine prostate cancer
por: Ivan de Kouchkovsky, et al.
Publicado: (2024)

Other‐cause mortality in incidental prostate cancer
por: Francesco Di Bello, et al.
Publicado: (2024)

Consistent predictive ability of prostate‐specific antigen density prediction model for clinically significant prostate cancer across age strata
por: Kamil Malshy, et al.
Publicado: (2024)

Analysis of three primary prostatic sarcoma cases and literature review
por: Yirui Wei, et al.
Publicado: (2024)

FOXA1 regulates ribosomal RNA transcription in prostate cancer
por: Tianwei Jia, et al.
Publicado: (2024)

Translation and validation of a lifestyle questionnaire related to prostate cancer
por: Reyhane Karegar‐Niavol, et al.
Publicado: (2024)

Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy
por: Thomas Büttner, et al.
Publicado: (2024)

The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low‐intensity extracorporeal shock wave
por: Xiangbin Kong, et al.
Publicado: (2024)

Investigation of pelvic floor influence on prostate displacement in image‐guided radiotherapy
por: Hongbo Chai, et al.
Publicado: (2024)

Three‐dimensional ultrastructural and anatomical analysis of prostatic neuroendocrine cells in mice
por: Kei‐Ichiro Uemura, et al.
Publicado: (2024)

Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate
por: Chinade Roper, et al.
Publicado: (2024)

Retrospective analysis of the learning curve in perineal robot‐assisted prostate biopsy
por: Ruth Himmelsbach, et al.
Publicado: (2024)

The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy‐naive patients, according to the localization of the lesion at the mpMRI: A single‐center retrospective observational study
por: Matteo Massanova, et al.
Publicado: (2024)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
por: Tatsuya Shimomura, et al.
Publicado: (2026)

Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer
por: Fabian Falkenbach, et al.
Publicado: (2024)

Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era
por: Sean A. Fletcher, et al.
Publicado: (2024)

Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing
por: Stephen Schmit, et al.
Publicado: (2024)

Performance of large language models on benign prostatic hyperplasia frequently asked questions
por: YuNing Zhang, et al.
Publicado: (2024)

L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells
por: Chia‐Ling Hsieh, et al.
Publicado: (2024)

Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix
por: Shuhei Kamada, et al.
Publicado: (2024)

Development and validation of an imageless machine‐learning algorithm for the initial screening of prostate cancer
por: Nicolas Martelin, et al.
Publicado: (2024)

Distribution of neurovascular structures within the prostate gland and their relationship to complications after radical prostatectomy
por: Ghazi Alanazi, et al.
Publicado: (2024)

Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome
por: Eli Marie Grindedal, et al.
Publicado: (2024)

Assessing state‐of‐the‐art online large language models for patient education regarding prostatitis
por: Pengfei Zhang, et al.
Publicado: (2024)

Serum levels of prostate specific antigen, free PSA, [−2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
por: Michal Jirásko, et al.
Publicado: (2024)

Real‐world study: Impact of multidisciplinary management of apalutamide‐associated adverse events in prostate cancer
por: Julián Córdoba Sánchez, et al.
Publicado: (2024)

PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer
por: Philip Sutera, et al.
Publicado: (2024)

Machine learning and explainable artificial intelligence to predict pathologic stage in men with localized prostate cancer
por: Hemal Semwal, et al.
Publicado: (2024)

Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review
por: Ahmad Abid, et al.
Publicado: (2024)

An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors
por: Naz Chaudary, et al.
Publicado: (2024)

Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67
por: Fengnian Zhao, et al.
Publicado: (2024)